A new scientific review highlights CBD's potential to treat various conditions such as epilepsy, pain, cancer, schizophrenia, diabetes, and COVID-19. The review aims to summarize cannabis's impact on human health, noting its “neuroprotective, anti-inflammatory, and pain-relieving properties”. The study delves into CBD's pharmacological properties, mechanisms of action, and its potential medical applications. It discusses CBD's role in treating epilepsy, pain relief, managing schizophrenia symptoms, and its potential as a COVID-19 inhibitor. The review also touches upon CBD's promising anticancer properties and its effects on diabetes-related processes. “Cannabis exhibits neuroprotective, anti-inflammatory, anti-thrombotic, anti-bacterial, analgesic, and antiepileptic properties.” Additionally, it acknowledges the industrial applications of CBD and hemp in pharmaceuticals, skincare, fuel, paper, clothing, rope, and massage oil production.